Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/16/2003CA2480505A1 Use of botulinum toxin for treating cardiovasular diseases
10/16/2003CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003CA2479810A1 Polymeric acyl derivatives of indoles
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352910A1 New analogs of nitrobenzylthioinosine
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352651A2 Novel use of orexin receptor antagonists
10/15/2003EP1352073A2 Electrically responsive promoter system
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351971A2 Compounds useful for treating hypertriglyceridemia
10/15/2003EP1351968A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/15/2003EP1351962A2 Thienopyrimidine
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351942A1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351744A2 Erbb4 antagonists
10/15/2003EP1351698A2 Herbal composition for angina pectoris, method to prepare same and uses thereof
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351687A2 Urotensin-ii receptor antagonists
10/15/2003EP1351686A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1351682A1 Regulation of lipids and/or bone density and compositions therefor
10/15/2003EP1351681A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/15/2003EP1351673A1 Compositions of stable t 3? and methods of use thereof
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP1351573A1 Methods for modulating tumor growth and metastasis
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1206457B1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
10/15/2003EP1007096B1 Arginine silicate inositol complex and use thereof
10/15/2003EP1005332B1 Pharmaceutical composition for reducing production of mcp-1 protein
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003EP0855391B1 Novel isoquinoline derivatives
10/15/2003EP0797575B1 Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
10/15/2003EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449381A New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them
10/15/2003CN1449291A Novel specific mechanism for inhibiting adherence of platelets to collagen
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449286A Carvedilol
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/15/2003CN1448397A Process of extracting total flavone glycoside from mistletoe and medicine composition thereof
10/15/2003CN1448178A Medicine for curing piles
10/15/2003CN1448172A Folium ginkgo injection and preparation thereof
10/15/2003CN1448158A Antiatherosclerosis medicine
10/15/2003CN1448157A Traditional medicine prescription for radical cure of hemorrhoidal fistula
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/15/2003CN1124258C Substituted dihydropyridine dicarboxylic ester
10/15/2003CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds
10/15/2003CN1124154C Medicine for treating piles and its preparing process
10/15/2003CN1124153C Medicinal composition for restoring cardiac collaterals and its application
10/15/2003CN1124149C Chinese medicine capsule mainly for treating cerebral infraction
10/15/2003CN1124148C Traditional Chinese medicine for curing viral myocarditis and its preparing process
10/15/2003CN1124141C Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
10/15/2003CN1124135C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/14/2003US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632460 Treating angina pectoris, reducing the usage of nitroglycerin
1 ... 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 ... 1595